As of January 22, 2025, Aileron Therapeutics (ALRN) has a market cap of $45.715 million USD. According to our data, Aileron Therapeutics is ranked No.8210 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $45.72 M |
-8.26%
|
Dec 31, 2024 | $49.83 M |
-24.56%
|
Dec 29, 2023 | $66.05 M |
28.63%
|
Dec 30, 2022 | $51.35 M |
-78.95%
|
Dec 31, 2021 | $0.24 B |
-45.87%
|
Dec 31, 2020 | $0.45 B |
81.50%
|
Dec 31, 2019 | $0.25 B |
-31.79%
|
Dec 31, 2018 | $0.36 B |
-92.03%
|
Dec 29, 2017 | $4.57 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Market Cap | = | ALRN Stock Price | * | ALRN Shares Outstanding |
= | $1.94 | * | 21.67 M | |
= | $45.72 M |